Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
eNq1mF1v2jAUhu/5FVHuSaDjI5sC1cbaDalVGS3atJvKJIdiFuz02KaUXz+H0JVOjkpNfZnYec+Jz+vHR45P18vMWwEKylnPbwYN3wOW8JSyu54/uTmvR/5pvxYvyIo8TzvR84Jm0/eSjAjR84vRYAqEieDX5cVX0N8D+v2aF/PpAhL5Yp6SNAu+EzG/JHkxx4tXnKbeEuScpz0/V3L71ouFRJ1F/4HjH5GTBOJw92Z/dHHb2n8fh4XYAapKAF4QdmcUBWalmShEYHJAJNxxfDRKz5Lbk6jbaTQiqxBUjEFwhQmMiJyPkK9oCqk5EskEWAWZPaTXgKsMZBHEKB4ukqWwEicLsh7D/dCc9Gc9OpBrWW/Um90oareibrfVbTesQuHeUpnNo38i1AX52GlHnZMQWCgh0RVEel/XRdzwjG7UkkwtSzXiKEnmqEhUDF7azVEchPtXzZBSkWfkMViI3HapCBI9DKih4O5Hij+4QY2pTK/Zf/pMZVn4xqwnO4g4yrhg1IAr7UczS87Htgsx4EzCurqidviT650XKYj3k91wZkb/SE0zmtgSTjNIgZCT8bAacA7Z8IUImKA7OPykLOUP4v2hs19kR9nnW24aRXNMm7omUafZblvvqd/aURXnz5lCnkOocUTFMZQZshk/li/apGapJ4u6cue2N+IJyaCiO6pbkkfb8qmZc2Z8d5uqHDCKfju7sXXLDwX4eL19NErTtPevznZYdsF67c3KxN/u9HLDH9A3t6IPdoug0MyTuZS5+BSGcyLqguiFCmboGv17h6+7Bt7JCV92PCU+HaU+Lc/Fw4tlu+9eO/+P7Wl33+96Z2MMiQqOqEOJaGcgHZ69P5ufG1pnaY9esMRdmG3zSSTlzFUXpKZGxeNOA11Xdo4aDlezGa24U6n0ZRyW9zn9WhwWdzn92l9Cmv2a
2g93xgb7r55yxv0n
